1. World Health Organization. Human papillomavirus (HPV) and cervical cancer [Internet]. WHO. 2020 [cited 2024 Oct 8]. Available from: https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer
2. Zhao J, Zhu Y, Cheng J, et al. Detection of HPV16 and HPV18 DNA by FRET-based real-time PCR. Clin Chem Lab Med. 2019;57(2):276-282.
3. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-19.
4. Roda Husman AM, Walboomers JM, Van den Brule AJ, et al. The use of general primers GP5 and GP6 elongated with a homologous linker for detection of a broad spectrum of human papillomavirus genotypes by PCR. J Gen Virol. 1995;76(Pt 4):1057-1062.
5. Schiffman M, Castle PE. The promise of global cervical-cancer prevention. N Engl J Med. 2005;353(20):2101-2104.
6. Castle PE, Maza M. Prophylactic HPV vaccination: past, present, and future. Epidemiol Infect. 2016;144(3):449-468.
7. Wheeler CM. Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing. Nat Rev Cancer. 2007;7(6):351-360.
8. Quan K, Yi C, Yang X, et al. Rapid and highly sensitive detection of target DNA related to COVID-19 virus with a fluorescent bio-conjugated probe via a FRET mechanism. J Fluoresc. 2021;31:715-723.
9. Tsao YP, Li LY, Tsai TC, et al. Amplification and detection of human papillomavirus DNA using a FRET-based quantitative PCR. Biochem Biophys Res Commun. 2006;348(3):999-1007..
10. Peptide substrate screening for the diagnosis of SARS-CoV-2 using fluorescence resonance energy transfer (FRET) assay. Microchimica Acta. [Internet]. [cited 2024 Oct 8]; Available from: https://link.springer.com/article/10.1007/s00604-020-04503-4
11. Single-Molecule FRET Imaging of Virus Spike–Host Interactions. MDPI Viruses. [Internet]. 2021 [cited 2024 Oct 8]. Available from: https://www.mdpi.com/1999-4915/13/2/332.
12. Castle PE, Sadorra M. Cervical cancer prevention and the promise of HPV vaccination. Vaccine. 2011;29 Suppl 5.
13. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-19.
14. Castle PE, Maza M. Prophylactic HPV vaccination: past, present, and future. Epidemiol Infect. 2016;144(3):449-468.
15. Lorincz AT. Molecular methods for the detection of human papillomavirus infection. Obstet Gynecol Clin North Am. 1996;23(3):707-730.
16. Cox JT, Lorincz AT, Schiffman MH, et al. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 1995;172(3):946-954.
17. Zhao J, Zhu Y, Cheng J, et al. Detection of HPV16 and HPV18 DNA by FRET-based real-time PCR. Clin Chem Lab Med. 2019;57(2):276-282.
18. Castle PE, Sadorra M. Cervical cancer prevention and the promise of HPV vaccination. Vaccine. 2011;29 Suppl 5
19. Resende LS, Rabelo MA, Andrade-Moraes GD, et al. Validation of a real-time PCR assay for HPV genotyping in cervical samples. PLoS One. 2019;14(3)
20. Peptide substrate screening for the diagnosis of SARS-CoV-2 using fluorescence resonance energy transfer (FRET) assay. Microchim Acta. 2020;187(10):580.
21. Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012;137(4):516-542.
22. Bardajee, G.R., Zamani, M., Sharifi, M. et al. Rapid and Highly Sensitive Detection of Target DNA Related to COVID-19 Virus With a Fluorescent Bio-conjugated Probe via a FRET Mechanism. J Fluoresc 32, 1959–1967 (2022).
